Variant report

Variant	nsv9501
Chromosome Location	chr17:17623197-17628790
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:24)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:17623498..17628448-chr17:17639518..17645523,5	MCF-7	breast:
2	chr17:17623385..17625295-chr17:17685917..17688281,2	MCF-7	breast:
3	chr17:17621090..17625652-chr17:17628958..17633678,4	K562	blood:
4	chr17:17612154..17614264-chr17:17622183..17624115,2	K562	blood:
5	chr17:17616640..17621163-chr17:17622040..17627772,6	K562	blood:
6	chr17:17618965..17621163-chr17:17622040..17625612,4	K562	blood:
7	chr17:17622227..17624857-chr17:17737770..17740732,3	MCF-7	breast:
8	chr17:17621661..17623884-chr17:17711549..17713112,2	MCF-7	breast:
9	chr17:17625971..17628636-chr17:17738539..17741312,3	MCF-7	breast:
10	chr17:17582718..17591238-chr17:17621630..17636217,47	MCF-7	breast:
11	chr17:17588968..17590942-chr17:17625144..17626762,2	K562	blood:
12	chr17:17623309..17626768-chr17:17630272..17633678,3	K562	blood:
13	chr17:17624565..17630367-chr17:17651647..17657037,7	MCF-7	breast:
14	chr17:17625914..17628090-chr17:17681908..17683925,2	MCF-7	breast:
15	chr17:17591306..17603641-chr17:17622226..17637880,43	MCF-7	breast:
16	chr17:17626085..17630406-chr17:17685140..17688350,6	MCF-7	breast:
17	chr17:17626989..17629542-chr17:17738843..17741438,3	MCF-7	breast:
18	chr17:17588060..17590556-chr17:17627029..17629581,4	K562	blood:
19	chr17:17628659..17631586-chr17:17715633..17718391,2	MCF-7	breast:
20	chr17:17622624..17624957-chr17:17740328..17743276,2	K562	blood:
21	chr17:17625723..17629618-chr17:17942573..17946112,3	MCF-7	breast:
22	chr17:17588589..17591181-chr17:17627029..17629351,3	K562	blood:
23	chr17:17626970..17628533-chr17:17712241..17714869,2	MCF-7	breast:
24	chr17:17623843..17637985-chr17:17653006..17664308,33	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000108557	chromatin interactions
ENSG00000072310	chromatin interactions
ENSG00000207839	chromatin interactions
ENSG00000226746	chromatin interactions
ENSG00000141034	chromatin interactions

Extended variants
information (count: 202 )
Associated
traits (count: 162 )

Variant overlapped rSNPs/rCNVs (count:202 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183542169	chr17:17623198-17623199	Weak transcription Enhancers Strong transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs536633087	chr17:17623215-17623216	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs145075209	chr17:17623228-17623229	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs576530398	chr17:17623331-17623332	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs373048799	chr17:17623372-17623373	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs8080920	chr17:17623402-17623403	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs8079801	chr17:17623415-17623416	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs8079802	chr17:17623418-17623419	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs559213500	chr17:17623435-17623436	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs572540340	chr17:17623458-17623459	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs187216060	chr17:17623469-17623470	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs560632438	chr17:17623493-17623494	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs368204889	chr17:17623526-17623527	Weak transcription Enhancers Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs574158080	chr17:17623625-17623626	Enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs543134408	chr17:17623631-17623632	Enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs562896815	chr17:17623647-17623648	Enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs191722025	chr17:17623672-17623673	Enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs36008551	chr17:17623680-17623681	Enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs535433201	chr17:17623752-17623753	Enhancers Transcr. at gene 5' and 3' Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs533709945	chr17:17623821-17623822	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs183494631	chr17:17623826-17623827	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs528252589	chr17:17623848-17623849	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs375586526	chr17:17623850-17623851	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs568277941	chr17:17623943-17623944	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs188198241	chr17:17623968-17623969	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs550303646	chr17:17623977-17623978	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs569912467	chr17:17623978-17623979	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs9897309	chr17:17623988-17623989	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs115811365	chr17:17623998-17623999	Enhancers Flanking Active TSS Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs117715914	chr17:17624026-17624027	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs557120762	chr17:17624044-17624045	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs535019618	chr17:17624075-17624076	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs554713225	chr17:17624143-17624144	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs573100504	chr17:17624159-17624160	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs575682644	chr17:17624186-17624187	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs199504574	chr17:17624193-17624194	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs556286866	chr17:17624199-17624200	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs368670512	chr17:17624228-17624229	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs558164550	chr17:17624284-17624285	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs77904527	chr17:17624349-17624350	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs370734399	chr17:17624353-17624354	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs535790723	chr17:17624391-17624392	Enhancers Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs555999080	chr17:17624451-17624452	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs143176806	chr17:17624491-17624492	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs542167084	chr17:17624509-17624510	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs199756556	chr17:17624518-17624519	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs148276924	chr17:17624564-17624565	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs572582973	chr17:17624595-17624596	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs142681648	chr17:17624635-17624636	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs550291067	chr17:17624739-17624740	Bivalent Enhancer Weak transcription Strong transcription Genic enhancers Bivalent/Poised TSS Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:162)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22543975	CNVD
Melanoma	22183965	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Autism	19492091	CNVD
Ovarian cancer	22355333	CNVD

Chromatin state (count:720 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:17613600-17624400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr17:17616000-17624800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr17:17616000-17625000	Weak transcription	Brain Germinal Matrix	brain
4	chr17:17616200-17625200	Weak transcription	Sigmoid Colon	Sigmoid Colon
5	chr17:17616200-17642000	Weak transcription	K562	blood
6	chr17:17617600-17623400	Weak transcription	Colonic Mucosa	Colon
7	chr17:17617600-17625800	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
8	chr17:17617800-17625200	Weak transcription	Primary T helper cells fromperipheralblood	blood
9	chr17:17618000-17623200	Weak transcription	Primary B cells from peripheral blood	blood
10	chr17:17618000-17623400	Weak transcription	Hela-S3	cervix
11	chr17:17618200-17624800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr17:17618200-17625400	Weak transcription	Brain Substantia Nigra	brain
13	chr17:17618200-17626600	Weak transcription	HSMM	muscle
14	chr17:17618400-17623600	Weak transcription	Placenta Amnion	Placenta Amnion
15	chr17:17618400-17624600	Strong transcription	Fetal Stomach	stomach
16	chr17:17618400-17624800	Weak transcription	Osteobl	bone
17	chr17:17618400-17626800	Weak transcription	Pancreatic Islets	Pancreatic Islet
18	chr17:17618600-17623200	Weak transcription	Right Atrium	heart
19	chr17:17618600-17623400	Weak transcription	Fetal Muscle Leg	muscle
20	chr17:17618600-17623600	Weak transcription	Adipose Nuclei	Adipose
21	chr17:17618600-17623800	Weak transcription	Monocytes-CD14+_RO01746	blood
22	chr17:17618600-17624800	Weak transcription	Fetal Brain Female	brain
23	chr17:17618800-17623200	Weak transcription	Brain Inferior Temporal Lobe	brain
24	chr17:17618800-17624800	Weak transcription	Colon Smooth Muscle	Colon
25	chr17:17618800-17625400	Weak transcription	Muscle Satellite Cultured Cells	--
26	chr17:17618800-17626000	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr17:17619200-17623200	Weak transcription	Lung	lung
28	chr17:17619400-17623400	Weak transcription	Stomach Mucosa	stomach
29	chr17:17619800-17623200	Weak transcription	Brain Angular Gyrus	brain
30	chr17:17620000-17624800	Weak transcription	Fetal Brain Male	brain
31	chr17:17620200-17625200	Weak transcription	Brain Anterior Caudate	brain
32	chr17:17620400-17625200	Weak transcription	Ovary	ovary
33	chr17:17620400-17625800	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr17:17620600-17623400	Weak transcription	Fetal Muscle Trunk	muscle
35	chr17:17620600-17624800	Weak transcription	Fetal Intestine Large	intestine
36	chr17:17620800-17623200	Strong transcription	Fetal Adrenal Gland	Adrenal Gland
37	chr17:17620800-17625000	Enhancers	HepG2	liver
38	chr17:17620800-17626200	Weak transcription	Duodenum Mucosa	Duodenum
39	chr17:17621000-17624800	Strong transcription	Fetal Intestine Small	intestine
40	chr17:17621000-17625400	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
41	chr17:17621200-17624800	Genic enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr17:17621200-17625000	Weak transcription	NHLF	lung
43	chr17:17621200-17626000	Weak transcription	Liver	Liver
44	chr17:17621400-17625600	Enhancers	Right Ventricle	heart
45	chr17:17621600-17623600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
46	chr17:17621600-17624800	Strong transcription	H9 Derived Neuron Cultured Cells	ES cell derived
47	chr17:17621600-17625000	Weak transcription	Cortex derived primary cultured neurospheres	brain
48	chr17:17621600-17625200	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
49	chr17:17621600-17625200	Weak transcription	Primary T cells from cord blood	blood
50	chr17:17621600-17625800	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links